Tuberculosis | Esophageal candidiasis | Cerebral Toxoplamosis | PCP | |
---|---|---|---|---|
(N = 30) | (N = 10) | (N = 12) | (N = 8) | |
HR (CI) | HR (CI) | HR (CI) | HR (CI) | |
Gender-Risk | ||||
Women | Ref. | Ref. | Ref. | Ref. |
Heterosexual men | 0.82 (0.37–1.82) | 0.16 (0.02–1.39) | 1.10 (0.27–4.43) | 0.90 (0.17–4.73) |
MSM | 0.49 (0.16–1.48) | 0.37 (0.06–2.24) | 0.34 (0.04–2.71) | 0.57 (0.08–4.09) |
Age (per year) | 1.02 (0.98–1.06) | 0.94 (0.86–1.02) | 0.90 (0.82–0.99) | 1.07 (1.00–1.14) |
Race/ethnicity | ||||
White | Ref. | Ref. | Ref. | Ref. |
Non-white | 0.90 (0.41–2.00) | 1.84 (0.35–9.51) | 0.53 (0.14–1.92) | 1.05 (0.21–5.19) |
Educational level | ||||
0–8 years | 1.89 (0.70–5.12) | 1.05 (0.22–5.12) | 1.46 (0.34–6.33) | 0.44 (0.08–2.41) |
9+ years | Ref. | Ref. | Ref. | Ref. |
Nadir CD4+ T lymphocyte (per 100 cells/mm3) | 0.88 (0.62–1.24) | 0.95 (0.50–1.79) | 1.17 (0.85–1.61) | 1.15 (0.73–1.83) |
Last CD4+ Tlymphocyteª (per/100 cells/mm3) | 0.95 (0.80–1.13) | 0.87 (0.61–1.23) | 0.70 (0.49–0.99) | 1.09 (0.90–1.33) |
Last HIV viral loadb | ||||
<400 copies/mm3 | Ref. | Ref. | Ref. | Ref. |
>400 copies/mm3 | 0.35 (0.08–1.56) | 4.45 (0.98–20.19) | 3.04 (0.73–12.58) | 2.57 (0.42–15.88) |
Opportunistic illness at enrollment | 23.01 (9.44–56.09) | 15.52 (3.38–71.30) | 31.96 (8.31–123.88) | 21.83 (2.85–167.29) |
Time under cART (per year) | 0.79 (0.63–0.99) | 0.71 (0.40–1.28) | 0.70 (0.44–1.12) | 0.60 (0.33–1.08) |